Showing results (161-170 of 232) with videos related to
Sort By:
Pageof 24
British Journal of Cancer|December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation studyJ T Hartmann, K Oechsle, D Quietzsch, et al.Magnetic Resonance in Medicine|April 2, 2021
Lipid droplet-size mapping in human adipose tissue using a clinical 3T systemDominik Weidlich, Julius Honecker, Christof Boehm, et al.Magnetic Resonance in Medicine|January 18, 2019
Measuring large lipid droplet sizes by probing restricted lipid diffusion effects with diffusion-weighted MRS at 3TDominik Weidlich, Julius Honecker, Oliver Gmach, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|October 4, 2016
IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumoniaLisa Wolf, Sandra Sapich, Anja Honecker, et al.Oncotarget|October 10, 2015
Role of N-cadherin in proliferation, migration, and invasion of germ cell tumoursFelix Bremmer, Simon Schallenberg, Hubertus Jarry, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2011
Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative studyK Oechsle, F Honecker, T Cheng, et al.BJU International|October 20, 2010
Histopathological and molecular features of late relapses in non-seminomasFrank Mayer, Hendrik Wermann, Peter Albers, et al.Journal of Proteome Research|July 23, 2008
Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell lineStephanie Glaesener, Friedemann Honecker, Imke M Veltman, et al.Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Deep Learning Derived Adipocyte Size Reveals Adipocyte Hypertrophy is under Genetic ControlEmil Jørsboe, Phil Kubitz, Julius Honecker, et al.Oncology|March 14, 2015
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)Günter Niegisch, Margitta Retz, Mark Thalgott, et al.Pageof 24